Search Results
MCP 60 Seconds With Dr Nicholas Vogelzang on Mesothelioma
Nicholas Vogelzang, MD, FASCO, FACP, describes the role of PARP inhibitors advanced prostate cancer
Nicholas Vogelzang, MD, FASCO, FACP, on the evolving treatment landscape of nmCRPC
